Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

RANBP17 anticorps (AA 465-587) (FITC)

RANBP17 Reactivité: Humain Hôte: Lapin Polyclonal FITC
N° du produit ABIN7167092
  • Antigène Voir toutes RANBP17 Anticorps
    RANBP17 (RAN Binding Protein 17 (RANBP17))
    Épitope
    • 9
    • 8
    • 5
    • 3
    • 1
    • 1
    • 1
    AA 465-587
    Reactivité
    • 27
    • 11
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 27
    Lapin
    Clonalité
    • 27
    Polyclonal
    Conjugué
    • 9
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp RANBP17 est conjugé à/à la FITC
    Application
    Veuillez nous consulter SVP
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Ran-binding protein 17 protein (465-587AA)
    Isotype
    IgG
    Top Product
    Discover our top product RANBP17 Anticorps primaire
  • Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    RANBP17 (RAN Binding Protein 17 (RANBP17))
    Autre désignation
    RANBP17 (RANBP17 Produits)
    Synonymes
    anticorps RGD1562576, anticorps RANBP17, anticorps 4932704E15Rik, anticorps RAN binding protein 17, anticorps Ranbp17, anticorps RANBP17, anticorps ranbp17
    Sujet

    Background: May function as a nuclear transport receptor.

    Aliases: FLJ32916 antibody, RAN binding protein 17 antibody, Ran-binding protein 17 antibody, RanBP 17 antibody, Ranbp17 antibody, RBP17_HUMAN antibody

    UniProt
    Q9H2T7
    Pathways
    Protein targeting to Nucleus
Vous êtes ici: